Syneron Bio Raises $150 Million in Series B Financing to Enhance Drug Discovery Platform Syneron Bio has successfully completed $150 million in Series B financing to boost its macrocyclic peptide drug development efforts and clinical pipeline enhancements.

Syneron Bio Raises $150 Million in Series B Financing to Enhance Drug Discovery Platform #China #Beijing #Syneron_Bio #Synova #macrocyclic_peptides

Syneron Bio Secures Nearly $100 Million in Series A and A+ Funding Rounds Syneron Bio has successfully raised close to $100 million in Series A and A+ funding, thanks to support from leading global pharmaceutical firms.

Syneron Bio Secures Nearly $100 Million in Series A and A+ Funding Rounds #China #Beijing #AstraZeneca #Syneron_Bio #Synova

GTCR and Synova Complete Acquisition of UK Insurance Broker JMG Group GTCR and Synova have successfully finalized their acquisition of JMG Group, a prominent UK insurance broker. This partnership aims to enhance JMG's growth and service capabilities.

GTCR and Synova Complete Acquisition of UK Insurance Broker JMG Group #United_Kingdom #Leeds #GTCR #JMG_Group #Synova

GTCR and Synova Finalize Acquisition of JMG Group, Expanding Their Investment Portfolio GTCR and Synova announce the successful acquisition of JMG Group, a leading UK insurance broker, enhancing their investment strategies and market presence.

GTCR and Synova Finalize Acquisition of JMG Group, Expanding Their Investment Portfolio #United_Kingdom #Leeds #GTCR #JMG_Group #Synova